AbbVie

$110.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.61 (+1.48%) As of 4:31 PM UTC today

Why Robinhood?

You can buy or sell AbbVie and other stocks, options, and ETFs commission-free!

About ABBV

ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

CEO
Richard A. Gonzalez
Employees
47,000
Headquarters
North Chicago, Illinois
Founded
2011
Market Cap
192.17B
Price-Earnings Ratio
39.88
Dividend Yield
4.46
Average Volume
7.19M
High Today
$111.44
Low Today
$109.40
Open Price
$109.64
Volume
2.90M
52 Week High
$113.41
52 Week Low
$79.11

ABBV News

BenzingaApr 15

Sound Mind Heads To Southern California For Third Annual Mental Health Music Festival On May 20

LOS ANGELES, April 15, 2021 /PRNewswire/ -- Today, Sound Mind Live announced the return of its annual SOUND MIND MENTAL HEALTH MUSIC FESTIVAL, which will take p

ABBV Earnings

$0.00
$0.97
$1.95
$2.92
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 30, Pre-Market

You May Also Like

CPRT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure